General: 01252 416323   |   Fundraising: 07876 682589   |   Support: 0800 046 9832  
Screen Shot 2017 01 31 At 11.41.10

For all of our families with children and young people with CLN3 (Juvenile Batten disease), we are in regular contact with Abeona Therapeutics and have asked for clarification on whether families from outside of the US can access their forthcoming clinical trial. We have received the following information from them and we have asked to be kept updated on any changes or new information as it becomes available. This also includes information and timing concerning a site for the trial in Europe.

“At this time Abeona Therapeutics are focused on the necessary studies and efforts needed to enable regulatory allowance by the FDA here in the US. With that, we are working with the clinicians at University of Rochester, the selected initial site, to determine the design for the study and the criteria for participation. What we are having those interested in the study do is to place their information into the University of Rochester’s Institutional Review Board approved online contact registry if they are interested.

Click Here to Register

The University of Rochester Batten Center has more information on them.

Make a donation:

To make a donation to the BDFA please click the button below which will take you Paypal.

You can also TEXT DONATE 

Text the words BDFA15 £2 / £5 / £10 to 70070

All donations help us to provide the best support we can to families affected by Batten Disease.

Thank you for your support.